Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Indo Acidatama Tbk's earnings before interest and taxes (EBIT) for the
three
months ended in Jun. 2026 was Rp55,739 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was Rp171,432 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
PT Indo Acidatama Tbk's annualizedROC % for the quarter that ended in Jun. 2026 was 18.54%.
PT Indo Acidatama Tbk's annualizedROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 25.43%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
PT Indo Acidatama Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 41.86%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, PT Indo Acidatama Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Indo Acidatama Tbk EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PT Indo Acidatama Tbk's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PT Indo Acidatama Tbk's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp171,432 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Indo Acidatama Tbk (ISX:SRSN) has a EBIT of Rp171,432 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Indo Acidatama Tbk.
Is PT Indo Acidatama Tbk's EBIT too high?
PT Indo Acidatama Tbk's current EBIT is Rp171,432 Mil. Overall, PT Indo Acidatama Tbk has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Indo Acidatama Tbk's EBIT compare to DOW?
PT Indo Acidatama Tbk's EBIT of Rp171,432 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Indo Acidatama Tbk. PT Indo Acidatama Tbk's current EBIT is Rp171,432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Indo Acidatama Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Indo Acidatama Tbk (ISX:SRSN) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp59.93, compared to a current price of Rp71.00 — trading 18.5% above its estimated fair value. The current EBIT is Rp171,432 Mil. PT Indo Acidatama Tbk's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For PT Indo Acidatama Tbk (ISX:SRSN), the current EBIT is Rp171,432 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Indo Acidatama Tbk (ISX:SRSN) Overvalued in 2026?
Based on GuruFocus' analysis, PT Indo Acidatama Tbk stock appears to be overvalued.
The current stock price of Rp71.00 is trading 18.5% above its estimated GF Value™ of Rp59.93.
GuruFocus considers PT Indo Acidatama Tbk to be Modestly Overvalued.
Key valuation signals for ISX:SRSN:
EBIT: Rp171,432 Mil
GF Value™: Rp59.93 vs. price of Rp71.00 (18.5% above fair value)
No single metric tells the full story. See the ISX:SRSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Indo Acidatama Tbk is an Indonesian-based company engaged in manufacturing ethanol. The company produces acetic acid, ethyl acetate, bio-organic fertilizers, methylated spirit, and carbonic acid gas. It operates business activity in segments such as Ethanol, Acetic Acid, and Others. The fertilizers of the company are marketed under the brand names Pomi, Randex, Beka, and Alfinas. The company earns the majority of its revenue from the Ethanol segment.
86GF Score
Get the complete analysis for ISX:SRSN
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SRSN has been successfully added to your 
